Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Asian Stocks Up, Boosted by “Very Productive” U.S. Stimulus Talks

Published 02/02/2021, 02:04 pm
Updated 02/02/2021, 02:12 pm
© Reuters.

By Gina Lee

Investing.com – Asia Pacific stocks were up on Tuesday morning, advancing alongside their U.S. counterparts as talks were held about further U.S. stimulus measures. Concerns over volatile trading receded and progress on COVID-19 vaccinations also boosted investor sentiment.

Japan’s Nikkei 225 gained 0.96% by 10:01 PM ET (3:01 AM GMT) and South Korea’s KOSPI jumped 2.30%.

In Australia, the ASX 200 gained 1.28%. The Reserve Bank of Australia will hand down its policy decision later in the day.

Hong Kong’s Hang Seng Index rose 1.60 %. China’s Shanghai Composite was up 0.42% and the Shenzhen Component rose 1.23%.

Investor sentiment was boosted after a “very productive” two-hour meeting on Monday between U.S. President Joe Biden and a group of ten Republican senators who proposed a downsized COVID-19 stimulus package.

However, Biden is insisting on keeping the $1.9 trillion price tag that he proposed in January, saying that the downsized effort does not go far enough to solve the COVID-19 crisis.

Biden told the group “that he will not slow down work on this urgent crisis response and will not settle for a package that fails to meet the moment,” White House spokeswoman Jen Psaki said.

Fears that speculative buying will derail the equity bull market after the market volatility seen during the previous week also receded, adding to shares’ gains.

“We’re still positive on equities while acknowledging the near-term risk of more volatility … our view of a second half recovery supported by improvement from COVID-19 is still intact. The pace of recovery could vary by region, but the outlook of the U.S. and China, the world’s two largest economies, remains positive,” JPMorgan (NYSE:JPM) Asset Management chief Asia market strategist Tai Hui told Bloomberg.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Positive news came on the vaccine front, with the number of Americans who have received their first dose of the COVID-19 vaccine shot exceeding the number that tested positive for the virus. Across the Atlantic, German Chancellor Angela Merkel has vowed to offer all Germans a vaccine by the end of September, even if new shots are not approved by then.

Earnings season continues, with Alibaba (NYSE:BABA) Group Holding Ltd (HK:9988) and GlaxoSmithKline PLC (LON:GSK) among the companies announcing their results throughout the week.

The Bank of England will hand down its policy decisions on Thursday.

On the data front, the U.S.’ January payrolls report is due to be released on Friday. The report, which includes non-farm payrolls, will provide investors with a first glimpse of hiring in 2021.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.